rs116888435

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001080463.2(DYNC2H1):​c.1233A>G​(p.Gln411Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0165 in 1,561,178 control chromosomes in the GnomAD database, including 258 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.014 ( 26 hom., cov: 32)
Exomes 𝑓: 0.017 ( 232 hom. )

Consequence

DYNC2H1
NM_001080463.2 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.352

Publications

4 publications found
Variant links:
Genes affected
DYNC2H1 (HGNC:2962): (dynein cytoplasmic 2 heavy chain 1) This gene encodes a large cytoplasmic dynein protein that is involved in retrograde transport in the cilium and has a role in intraflagellar transport, a process required for ciliary/flagellar assembly. Mutations in this gene cause a heterogeneous spectrum of conditions related to altered primary cilium function and often involve polydactyly, abnormal skeletogenesis, and polycystic kidneys. Alternative splicing results in multiple transcript variants encoding distinct proteins. [provided by RefSeq, Jan 2010]
DYNC2H1 Gene-Disease associations (from GenCC):
  • asphyxiating thoracic dystrophy 3
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet, Ambry Genetics
  • Jeune syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • short rib-polydactyly syndrome, Majewski type
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • short rib-polydactyly syndrome, Verma-Naumoff type
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 11-103120787-A-G is Benign according to our data. Variant chr11-103120787-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 302010.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.352 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.0142 (2160/152092) while in subpopulation AMR AF = 0.0225 (343/15272). AF 95% confidence interval is 0.0205. There are 26 homozygotes in GnomAd4. There are 1019 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 26 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DYNC2H1NM_001080463.2 linkc.1233A>G p.Gln411Gln synonymous_variant Exon 8 of 90 ENST00000650373.2 NP_001073932.1 Q8NCM8-2
DYNC2H1NM_001377.3 linkc.1233A>G p.Gln411Gln synonymous_variant Exon 8 of 89 ENST00000375735.7 NP_001368.2 Q8NCM8-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DYNC2H1ENST00000650373.2 linkc.1233A>G p.Gln411Gln synonymous_variant Exon 8 of 90 NM_001080463.2 ENSP00000497174.1 Q8NCM8-2
DYNC2H1ENST00000375735.7 linkc.1233A>G p.Gln411Gln synonymous_variant Exon 8 of 89 1 NM_001377.3 ENSP00000364887.2 Q8NCM8-1

Frequencies

GnomAD3 genomes
AF:
0.0142
AC:
2164
AN:
151976
Hom.:
26
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00338
Gnomad AMI
AF:
0.0121
Gnomad AMR
AF:
0.0225
Gnomad ASJ
AF:
0.0395
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.0106
Gnomad FIN
AF:
0.00961
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.0194
Gnomad OTH
AF:
0.0234
GnomAD2 exomes
AF:
0.0160
AC:
2760
AN:
172070
AF XY:
0.0161
show subpopulations
Gnomad AFR exome
AF:
0.00365
Gnomad AMR exome
AF:
0.0136
Gnomad ASJ exome
AF:
0.0434
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0117
Gnomad NFE exome
AF:
0.0199
Gnomad OTH exome
AF:
0.0198
GnomAD4 exome
AF:
0.0167
AC:
23592
AN:
1409086
Hom.:
232
Cov.:
31
AF XY:
0.0169
AC XY:
11770
AN XY:
697192
show subpopulations
African (AFR)
AF:
0.00343
AC:
110
AN:
32072
American (AMR)
AF:
0.0139
AC:
513
AN:
36812
Ashkenazi Jewish (ASJ)
AF:
0.0407
AC:
1030
AN:
25280
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37020
South Asian (SAS)
AF:
0.0125
AC:
1011
AN:
80936
European-Finnish (FIN)
AF:
0.00942
AC:
463
AN:
49172
Middle Eastern (MID)
AF:
0.0372
AC:
186
AN:
4994
European-Non Finnish (NFE)
AF:
0.0177
AC:
19202
AN:
1084534
Other (OTH)
AF:
0.0185
AC:
1077
AN:
58266
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
1029
2058
3088
4117
5146
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
714
1428
2142
2856
3570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0142
AC:
2160
AN:
152092
Hom.:
26
Cov.:
32
AF XY:
0.0137
AC XY:
1019
AN XY:
74376
show subpopulations
African (AFR)
AF:
0.00337
AC:
140
AN:
41542
American (AMR)
AF:
0.0225
AC:
343
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.0395
AC:
137
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5188
South Asian (SAS)
AF:
0.0106
AC:
51
AN:
4830
European-Finnish (FIN)
AF:
0.00961
AC:
101
AN:
10510
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.0194
AC:
1320
AN:
67964
Other (OTH)
AF:
0.0227
AC:
48
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
109
218
326
435
544
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0195
Hom.:
34
Bravo
AF:
0.0148
Asia WGS
AF:
0.00810
AC:
28
AN:
3470

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 03, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

May 17, 2017
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Asphyxiating thoracic dystrophy 3 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Nov 25, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jeune thoracic dystrophy Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Short rib-polydactyly syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
3.7
DANN
Benign
0.53
PhyloP100
0.35
Mutation Taster
=92/8
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs116888435; hg19: chr11-102991516; API